Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization

Cancer Genetics and Cytogenetics

Volumn 89, Issue 1, 1996, Pages 7-13

  Kivipensas, Paula ^a   Björkqvist, Anna Maria ^b   Karhu, Ritva ^b   Pelin, Katarina ^a   Linnainmaa, Kaija ^a   Tammilehto, Lauri ^b   Mattson, Karin ^c   Kallioniemi, Olli Pekka ^b   Knuutila, Sakari ^d  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b Department of Epidemiology ^*

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL LINE; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MALIGNANT MESOTHELIOMA; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL;

EID: 0030199913     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00358-4     Document Type: Article

References (22)

1. 1. Browne K (1986): Mesothelioma registry data. Lancet ii 8499:167.
2. 2. Mossman BT, Gee J (1989): Asbestos-related diseases. N Engl J Med 320:1721-1730.
3. 3. Fearon ER, Vogelstein B (1990): A genetic model for colorectal tumorigenesis. Cell 61:758-767.
4. 4. Knuutila S, Tammilehto L, Mattson K (1994): Chromosomal abnormalities in human malignant mesothelioma. In: The Mesothelial Cell and Mesothelioma, Ed., M-C Jaurand, J Bignon, (eds). Marcel Dekker, Inc., New York, pp. 245-252.
5. 5. Tiainen M, Tammilehto L, Mattson K, Knuutila S (1988): Nonrandorn chromosomal abnormalities in malignant pleural mesothelioma. Cancer Genet Cytogenet 33:251-274.
6. 6. Hagemeijer A, Versnel MA, Van Drunen E, Moret M, Bouts MJ, van der Kwast ThH (1990): Cytogenetic analysis of malignant mesothelioma. Cancer Genet Cytogenet 47:1-28.
7. 7. Tiainen M, Tammilehto L, Rautonen J, Tuomi T, Mattson K, Knuutila S (1989): Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma. Br J Cancer 60:618-626.
8. 8. Pelin-Enlund K, Husgafvel-Pursiainen K, Tammilehto L, Klockars M, Jantunen K, Gerwin BI, Harris CC, Tuomi T, Vanhala E, Mattson K, Linnainmaa K (1990): Asbestos-related malignant mesothelioma: Growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients. Carcinogenesis 11:673-681.
9. 9. Pyrhönen S, Tiainen M, Rautonen J, Tammilehto L, Laasonen A, Mattson K, Knuutila S (1992): Comparison of DNA and karyotype ploidy in malignant mesothelioma. Cancer Genet Cytogenet 60:8-13.
10. 10. Meloni AM, Stephenson CF, Li FP, Sandberg AA (1992): del(6q) as a possible primary change in malignant mesothelioma. Cancer Genet Cytogenet 59:57-61.
11. 11. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR (1993): Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 53:4349-4355.
12. 12. Hansteen I-L, Hilt B, Lien JTh, Skaug V, Haugen A (1993): Karyotypic changes in the preclinical and subsequent stages of malignant mesothelioma: A case report. Cancer Genet Cytogenet 70:94-98.
13. 13. Metcalf RA, Welsh JA, Bennett WP, Seddon MB, Lehman TA, Pelin K, Linnainmaa K, Tammilehto L, Mattson K, Gerwin BI, Harris CC (1992): p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res 52:2610-2615.
14. 14. Cote RJ, Jhanwar SC, Novick S, Pellicer A (1991): Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. Cancer Res 51:5410-5416.
15. 15. Cheng JQ, Jhanwar SC, Lu YY, Testa JR (1993): Homozygous deletions within 9p21-22 identify a small critical region of chromosomal loss in human malignant mesotheliomas. Cancer Res 53:4761-4763.
16. 16. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992): Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
17. 17. du Manoir S, Speicher MR, Joos S, Schröck E, Lichter P, Cremer T (1993): Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90:590-610.
18. 18. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D (1994): Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chrom Cancer 10: 231-243.
19. 19. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM (1994): Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160.
20. 20. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH (1994): Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chrom Cancer 11: 153-162.
21. 21. Visakorpi T, Kallioniemi AH, Syvänen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi O-P (1995): Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
22. 22. Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schröck E, du Manoir S, Cremer T (1994): Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 54:1801-1806.